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Abstract
The use of pharmacologic MRI (phMRI) in mouse models of brain disorders allows noninvasive
in vivo assessment of drug-modulated local cerebral blood volume changes (ΔCBV) as one
correlate of neuronal and neuro-vascular activities. In this report, we employed CBV weighted
phMRI to compare cocaine-modulated neuronal activity in dopamine transporter (DAT) knockout
(KO) and wild-type mice. Cocaine acts to block the dopamine, norepinephrine and serotonin
transporters (DAT, NET and SERT) that clear their respective neurotransmitters from the
synapses, helping to terminate cognate neurotransmission. Cocaine consistently reduced CBV,
with a similar pattern of regional ΔCBV in brain structures involved in mediating reward in both
DAT genotypes. The largest effects (−20% to −30% ΔCBV) were seen in the nucleus accumbens
and several cortical regions. Decreasing response amplitudes to cocaine were noted in more
posterior components of the cortico-mesolimbic circuit. DAT KO mice had significantly
attenuated ΔCBV amplitudes, shortened times to peak response and reduced response duration in
most regions. This study demonstrates that DAT knockout does not abolish the phMRI responses
to cocaine, suggesting that adaptations to loss of DAT and/or retained cocaine activity in other
monoamine neurotransmitter systems underlie these responses in DAT KO mice.
Introduction
Assessment of the effects of psychotropic substances requires an understanding of their
sites, mechanisms and time-courses of action. Functional neuroimaging techniques have
made it possible to study drug-induced changes in brain activity in vivo (Leslie and James,
2000). Pharmacological magnetic resonance imaging (phMRI), a variant of functional MRI,
is well adapted to monitor drug action in the brain dynamically and noninvasively and to
map the brain systems and networks targeted by psychoactive drugs (Chen et al., 2001). A
number of important classes of medications used in the treatment of psychiatric disorders
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and many drugs of abuse target plasma membrane reuptake transporters for the monoamine
neurotransmitters dopamine, norepinephrine, and serotonin (DAT, NET, and SERT,
respectively) inhibiting the reuptake of the released neurotransmitters (Gainetdinov and
Caron, 2003).
Dopamine systems, including the cortico-mesolimbic system, are crucial for normal reward-
seeking behavior and are likely to make major contributions to the development of addiction
(Girault and Greengard, 2004). Cocaine is a prototypical psychomotor stimulant with
powerful mood altering properties (Johanson and Fischman, 1989; Uhl et al., 2002). It has
dramatic effects on the reward pathway through interaction with the monoamine transporters
(Gainetdinov and Caron, 2003). Moreover, chronic exposure has a multitude of effects in the
brain, including modulation of signaling cascades, neurotrophic factors, monoamine
receptors, and neuroplasticity (El-Ghundi et al., 2007; Thomas et al., 2008). Contrary to
initial expectations, DAT knockout (KO) mice display evidence for cocaine reinforcement
in conditioned place preference and even in some self-administration paradigms (Rocha et
al., 1998; Sora et al., 1998). However, in one line of DAT KO mice, individual mice differ
somewhat in their cocaine self-administration behavior. Most do not self-administer. Those
that do self-administer fail to continue responding when challenged with more demanding
schedules of reinforcement (Thomsen et al., 2009). This may be due to disruption of aspects
of incentive motivation (or aversion) mediated by dopamine, since DAT KO mice do not
exhibit cocaine conditioned locomotion (Hall et al., 2009). That cocaine is rewarding at all
in DAT KO mice may be, in part, a consequence of neuroadaptations in the SERT and NET
systems; consistent with the finding that SERT and NET blockers have reinforcing effects in
DAT KO mice that are not observed in wildtype mice (Hall et al., 2002). These data suggest
that although aspects of cocaine reward are maintained, at least to a certain degree, in DAT
KO mice, the mechanisms underlying cocaine reward differ from those in wildtype mice.
phMRI measures the hemodynamic responses to a pharmacological challenge, and thus
probes the activity of neuronal pathways targeted by the drug based on the neurovascular
consequences of changed neuronal (and vascular) activities (Jenkins et al., 2004; Mandeville
et al., 1998; Schwarz et al., 2007a). This technique has the potential for examining the
underlying changes in regional brain activity in mouse models of disorders that display links
to altered neurotransmitter activity, including attention deficit hyperactivity disorder,
narcolepsy, obesity, and drug addiction. However, small brain size, rapid metabolic rates,
susceptibility artifacts, and the need for anesthesia render functional MRI challenging in
mice. Small animal imaging is carried out at high magnetic field strengths (>7 Tesla) to
maximize signal intensity. In phMRI the sensitivity to functional changes is enhanced with
exogenous magnetic resonance contrast agents such as ultrasmall superparamagnetic iron
oxide particles (USPIO) that are retained in the blood pool and exhibit long circulation times
(Weissleder et al., 1990). The paramagnetic signals generated by such superparamagnetic
particles are so large that most of the MRI signal is determined by the cerebral blood volume
(CBV), overwhelming blood oxygen level dependent (BOLD) and blood flow effects. Most
current studies using this technique have used rats (Mandeville et al., 2004; Mandeville et
al., 1998; Schwarz et al., 2007b) or nonhuman primates (Jenkins et al., 2004). A few
research teams have successfully performed CBV weighted phMRI in mice (Luo et al.,
2008; Mueggler et al., 2003; Wu et al., 2004), although low signal to noise ration (SNR) and
sensitivity have precluded a broad range of investigations using genetically engineered
mouse models.
In the present report, we have examined, for the first time, effects of DAT gene deletion on
neurovascular responses to an acute cocaine challenge. We have used a CBV weighted
phMRI technique in mice and achieved good sensitivity to the CBV change with time
resolution of 1 minute and spatial resolution of < 0.2 mm. This methodology has already
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proved useful in larger rodent and primate systems (Chin et al., 2006; Jenkins et al., 2004;
Mandeville et al., 2005; Marota et al., 2000; Sanchez-Pernaute et al., 2007; Schwarz et al.,
2003). Adapting this approach for mouse brain imaging should provide a valuable means for
testing hypothesizes in a variety of mouse model systems.
Material and Methods
CBV responses to cocaine were studied in 6 DAT KO mice, and 6 wildtype control mice
consisting of 4 wildtype littermates and 2 C57BL/6J female mice (The Jackson Laboratory,
Bar Harbor, ME.). The DAT KO mice used in these experiments have been described
previously (Sora et al., 1998). Pilot experiments on isoflurane anesthetized mice of different
strains and ages were carried out to establish a suitable cocaine dose. In bench top
experiments that did not involve MRI, the electrocardiogram, respiration and expired CO2
(MicroCapStar CO2 Monitor, IITC Life Science Inc., CA) were continuously recorded
before and after cocaine injection. Criteria for the choice of the cocaine dose were: a) no
arousal from anesthesia and b) stable physiologic parameters after injection. Behavioral
changes have been reported starting at a cocaine dose of 5 mg/kg intraperitoneal (IP) in
conscious mice (Jamshidi et al., 2004), while cocaine induced seizures start to appear at a
dose of 70 mg/kg IP. Doses of 20 to 40 mg/kg IP increase striatal and nucleus accumbens
dopamine levels 3-fold in wild type mice (Mateo et al., 2004; Rocha et al., 1998). In this
work, cocaine hydrochloride (Sigma-Aldrich, MO) was dissolved in normal saline solution
(5 mg/ml) for IP injection at a dose of 30 mg/kg.
P904 (Guerbet Research, Aulnay-Sous-Bois, France) is a research prototype USPIO with a
hydrodynamic diameter of 25 to 30 nm and a glucose derivative coating designed for
macrophage and vascular imaging applications (Sigovan et al., 2009). It was provided as a
500 mM (≈ 28 mg/ml) solution and was diluted to 6 mg/ml in sterile normal saline solution
for IV injection. A volume of ≈ 4.2 µl/g body weight was injected IV resulting in a dose of
25 mg/kg.
All experiments were performed in accordance with protocols approved by the Institutional
Animal Care and Use Committee of the California Institute of Technology.
In vivo phMRI
In vivo MRI experiments were performed in a horizontal bore Bruker Biospec/Avance 7T/30
cm small animal MR system using a custom made 12-rung linear birdcage RF coil (length
45 mm, inner diameter 26 mm) for transmission and reception. The mice were positioned
prone in a plastic cradle with an integral head mask providing 1.5 to 1.7% isoflurane in N2/
O2 70%/30% and incorporated ECG electrodes for the front paws and tail. Rectal
temperature (Opsens OTGM, Canada) and respiration (BIOPAC Systems, CA) were
monitored continuously. Simultaneous recording of the electrocardiogram during gradient
echo imaging was not always reliable, but heart rates at the start and end of acquisition were
comparable. Body temperature was maintained between 36 and 38°C using heated air passed
through the RF coil and a cylindrical plastic extension that covered the mouse body,
preventing rapid loss of the warm air. The isoflurane level was adjusted to achieve
respiratory rates of 80 to 120 breaths per minute and was not changed during image
acquisition. The mice were fitted with tail vein catheters for USPIO injection and
intraperitoneal catheters for drug injection. Both catheters had extension lines with total
volumes of 200 µl and were preloaded with USPIO and drug in normal saline solution
before positioning the mouse in the magnet.
An autoshiming routine resulted in a 1H linewidth of < 0.13 ppm (FWHM) in a cube of 4 ×
4 × 4 mm3 brain tissue. After obtaining stable physiologic conditions, relative CBV maps
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were obtained based on the intravascular susceptibility effect of the USPIO (Berry et al.,
1996; Mandeville et al., 1998).
For each brain, 14 contiguous axial 0.75 mm thick slices, with a field of view of 19 × 19
mm2, were acquired from the olfactory bulb to the cerebellum using a 2D multiple gradient
echo sequence with TR = 600 ms, flip angle = 35°, 100 × 100 matrix, spectral line width 60
kHz, three echoes at TE = 2.5, 6.0 and 9.5 ms, and an acquisition time of 1 minute per
repetition.
Figure 1 illustrates the phMRI protocol: R2* weighted images were acquired for 30 minutes
prior to contrast agent administration followed by 30 post-contrast baseline acquisitions.
After the pharmacological challenge, image acquisition continued for 90 minutes. The
USPIO and cocaine were injected by flushing the IV/ IP catheter with 250 µl saline solution
over a duration of 1 minute while the mouse was positioned inside the scanner.
MRI data analysis
Pre-contrast and post-contrast images were automatically co-registered with a 2D rigid body
(3 parameters) model using Automated Image Registration (AIR) software (Woods et al.,
1998). Image analysis was performed with ImageJ (Abramoff et al., 2004). No spatial or
temporal smoothing was applied to the data.
The relative signal decrease upon contrast agent administration is
(1)
where SpreCA is the mean signal intensity prior to contrast agent (CA) injection and SpostCA
is the signal intensity averaged over the first five acquisitions after contrast agent injection
(Figure 1). The signal decrease depends on the relaxivity of the contrast agent and its initial
tissue concentration. These factors determine the transverse relaxation rate change
(2)
where TE is the echo time.
Prior to quantitative analysis, the signal intensity after contrast agent injection, S(t), was
detrended (Schwarz et al., 2003) to eliminate the effect of contrast agent washout by fitting
two time intervals of S(t) prior to and > 60 minutes after pharmacological challenge (Figure
1) to a two parameter model (Perles-Barbacaru et al., 2010). Assuming that the T2-weighted
signal is a simple exponential function (S0(t) ∝ exp[−TE R2*(t)]), we find that:
(3)
where SpreCA is defined as above. The fitting parameter κ provides an estimate of the initial
ΔR2* following USPIO injection (Equation 2), while τ−1 is the apparent washout rate of the
contrast agent from the tissue. In this model we assume negligible T1-effects, an
instantaneous USPIO bolus and mono-exponential USPIO washout in the plasma, since
USPIO is confined to the intravascular compartment.
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The relative CBV change (ΔCBV) is calculated for each image voxel according to
Mandeville et al. (1998) by assuming a linear relationship between CBV and ΔR2*:
(4)
where S0(t) represents the fit to the signal time-course after contrast agent injection under
resting conditions with no drug challenge (Equation 3). S(t) refers to the measured signal
after contrast agent injection. We analyzed the ΔCBV using the signal from the 3rd echo at
TE = 9.5 ms, while the ROIs were drawn on the images of the first two echoes.
Quantitative analyses of the parametric maps from Equation 4 describing the CBV change
upon cocaine injection were performed by examining several cerebral ROIs forming the
drug reward circuitry. We analyzed ROIs in the prefrontal, frontal and frontoparietal cortex
(CTX), nucleus accumbens (ACB), dorsal striatum (DS), amygdala (AMY), hippocampal
formation (HPF), thalamic nuclei (TH), hypothalamus (HY), midbrain (MB), ventral
tegmental area (VTA), substantia nigra (SNr), pons (P), medulla (MY) and cerebellum
(CBX). To rule out confounding systemic vascular changes associated with the
pharmacological stimulus and independent of neuronal activity, we also analyzed the signal
change in an extra-cerebral ROI located in the masseter or temporalis muscle.
To describe the regional time course of the ΔCBV response we used a simplified gamma
variate model
(5)
The three model parameters (ΔCBVpeak = amplitude, Tpeak = time to peak, and α = shape
factor) were compared between DAT KO and wildtype control groups using unpaired T-
tests. In particular, for each ROI noted above, the gamma variate model (Equation 5) was
fitted to the data of one animal at a time and to the combined data from all animals in one
group (examples for ACB and VTA can be seen in Figure 3). An F-test was used to compare
the relative difference in the sum of squares of the residuals from each fit and the relative
difference in the degrees of freedom. To test for significant differences in each model
parameter, an F-test was applied to the results of nonlinear regression with independent and
shared parameter of interest. T-tests for each model parameter confirmed the statistically
significant differences detected by the F-test. To test whether the entire response curves
were different the F-test was performed on the results of the nonlinear regression to the
separate data and to the combined data of both groups. P<0.01 was considered statistically
significant. Curve fitting and statistical tests were performed using GraphPad Prism version
4.03 for Windows (GraphPad Software, La Jolla, CA).
Results
During and within one minute after intravenous injection of P904, respiratory amplitudes
and rates were increased. Pilot experiments showed that cocaine doses up to 1.5 mg/kg IV or
30 mg/kg IP did not alter these physiologic parameters for more than 3 minutes. We
administered cocaine intraperitoneally during MRI experiments to avoid sudden
hypervolemia and to avoid the tail and body motion that often accompanied intravenous
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cocaine administration. An intraperitoneal dose of 30 mg/kg cocaine transiently reduced and
then increased the respiratory amplitude for 1 to 3 minutes.
Analysis of the signal from a ROI in the dorsal striatum (area 3.2 ± 0.2 mm2) acquired at TE
= 9.5 ms showed that a P904 dose of 25 mg/kg yielded a relative signal decrease (Equation
1) of 0.58 ± 0.02 during the 5 minutes following contrast agent injection with an apparent
tissue half-life (τ·ln2) of 156 ± 19 minutes (N = 12, average ± standard error of the mean).
Although the apparent tissue half-life computed according to Equation 3 does not vary from
region to region, it is greater than 2 hours in all regions. Thus, the detrending model in
Equation 3 takes reasonable account of the slowly decreasing P904 concentration.
Saline injection produced no measurable effect on CBV (data not shown). Figure 2 shows
that a spatially and temporally dependent CBV change was observed in cerebral tissue of
mice treated with cocaine, while there was no measurable effect on extra-cerebral
vasculature. Cocaine induced a marked CBV decrease (Figure 2) that lasted between 40 and
60 minutes. The ventral striatum/nucleus accumbens exhibited the strongest response to
cocaine. The time course of the ΔCBV response to cocaine in two ROIs within the
mesolimbic pathway is shown in Figure 3 for DAT KO and wildtype mice. The time-courses
in all examined ROIs, except thalamic nuclei, differed significantly between DAT
genotypes. Figure 4 shows that the DAT KO mice display an attenuated ΔCBV response in
all regions except the hypothalamus, thalamus, pons and medulla oblongata. Also, in the
knockout mice peak responses were reached at earlier time-points for most brain structures
and the total duration of the hemodynamic response to cocaine was shorter than in wildtype
mice (Figure 3 and 4).
Discussion
Drug induced CBV changes
Species differences in cerebral responses to cocaine have been reported previously (Lyons et
al., 1996; Zocchi et al., 2001), but have remain unexplained. In this study, a negative ΔCBV
response to cocaine was observed in mice. In rats, ΔCBV increases after cocaine challenge
have been observed with MRI (Ceolin et al., 2007; Marota et al., 2000; Schwarz et al., 2003;
Schwarz et al., 2004), while cocaine induced ΔCBV decreases have been observed in
humans (Kaufman et al., 1998). Mechanisms for the negative CBV response may be related
to reduced cerebrovascular feedback and/or decreased neuronal activation (Mandeville et al.,
2005; Peoples et al., 1998) accompanied by a decreased cerebral glucose metabolism (Lyons
et al., 1996; Thanos et al., 2008). Cerebral microvascular constriction has also been
observed in rhesus monkey brain slices upon micro-application of dopamine (Krimer et al.,
1998). Direct activation of D1 dopaminergic receptors on arterioles results in vasodilation
(Choi et al., 2006), although the sign of the CBV response depends on both the effective
concentration of dopamine and the relative regional densities of receptors in the D1/D5 and
D2/D3 and possibly even D4 receptor families (Choi et al., 2006). Cocaine-induced
blockade of norepinephrine and serotonin reuptake are also likely to influence the overall
direction of cardiovascular changes in both the wildtype, perhaps especially in the DAT KO
mice.
Confounding vascular effects
Vascular effects not related to neuroactivity also have to be considered when interpreting
phMRI results. Confounding systemic effects of cocaine have been difficult to exclude
(Gozzi et al., 2007; Luo et al., 2009). A limitation of the current study is that the arterial
blood pressure could not be monitored during scanning. However, the transient effect (~ 5
min) of this cocaine dose on the systemic blood pressure does not seem to provide a large
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determinant for the sustained (~ 1 h) hemodynamic response in the brain (Du et al., 2009;
Du et al., 2006; Luo et al., 2003; Schmidt et al., 2006). Moreover, any large peripheral blood
pressure change following cocaine injection would have resulted in a signal change in
muscle tissue. Our findings suggest that the measured CBV change in the current study is
largely independent of systemic effects of the drug.
There is evidence that the CBV response may depend on the type of anesthetic used in the
experiment (Du et al., 2009; Luo et al., 2009). In previous studies, which used different
anesthetics, the anesthetic used may have been confounded with apparent species
differences. In a study by Du and colleagues (Du et al., 2006), a CBV decrease of −4 to
−8% was observed with optical techniques in the cortex of rats under isoflurane anesthesia
after an intravenous dose of 1 mg/kg cocaine whether or not a peripheral blood pressure
decrease during the first minutes was prevented by phenylephrine. Consistent anesthesia
conditions were employed throughout the present work. Comparisons among the different
genotypes are thus credible, regardless of whether the nature of differences in CBV
responses between previous studies is the result of true species differences or procedural
differences (e.g. the choice of anesthetic). Nevertheless, care must be taken in comparisons
with conscious animals or with results from studies that use other anesthesia regimens.
Reward circuitry and monoamine transporter knockout mice
The cortico-mesolimbic dopaminergic circuit is thought to mediate many of the rewarding
effects of many drugs of abuse, including cocaine, which prolongs dopaminergic
transmission. However, cocaine also elevates extracellular serotonin and norepinephrine
levels (Li et al., 1996) which may account for its pronounced rewarding effects compared to
more selective agents. Rodents, in general, and monoamine transporter knockout mice, in
particular, have been used in efforts to identify the mechanisms of action of cocaine and
other drugs of abuse. A study by Schwarz and colleagues in rats (Schwarz et al., 2004) has
shown that the ΔCBV time course is not correlated with the local dopamine concentration or
with the local cocaine concentration in all brain regions. A more complex mechanism for the
ΔCBV response involving other neurotransmitters and downstream consequences of the
effects produced by cocaine is supported by the fact that, in our study, a straightforward
pharmacokinetic model did not fit the ΔCBV time-course. The ΔCBV response was,
therefore, described by a gamma variate model that allowed for a gradual onset of the ΔCBV
response.
In this study similar patterns of spatial activation were observed in both DAT KO and
wildtype mice. The largest negative responses were observed in the nucleus accumbens,
frontal and parietal cortex, dorsal striatum, and amygdala (in decreasing order). These
structures have substantial dopaminergic innervation and constitute a substantial portion of
the brain reward circuitry that mediates the rewarding effects of drugs of abuse (Koob and
Volkow, 2010). The time to peak response was 12–18 minutes in all structures examined,
except the cerebellum where it was 20–28 minutes. Quantitative regional analysis revealed a
significant decrease in amplitude and a slight decrease in duration of the hemodynamic
response in DAT KO mice compared to wildtype mice. The ΔCBV response to cocaine in
these regions was attenuated but not entirely abolished in DAT KO mice. This is consistent
with the maintenance of some reinforcing effects of cocaine in DAT KO mice at the cocaine
dose used here as indicated by conditioned place preference (Sora et al., 2001; Sora et al.,
1998) and cocaine self-administration (Rocha et al., 1998) studies. However, the reduced
ΔCBV response in DAT KO mice may also be considered to be consistent with the weaker
reinforcing effects that have been demonstrated in a more recent self-administration study
(Thomsen et al., 2009). More importantly, it may indicate a difference in the underlying
mechanism of cocaine effects in DAT KO and wildtype mice. Cocaine continues to produce
a conditioned place preference in DAT KO mice, but DAT KO mice also exhibit novel
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rewarding effects of selective SERT and NET blockers (Hall et al., 2002). The rewarding
effects of these drugs may be due to consequences of SERT and NET blockade in the VTA/
SN. Along with its rewarding effects, cocaine continues to produce increases in extracellular
dopamine in the striatum in this strain of DAT KO mice (Shen et al., 2004). This might be
due to cocaine blockade of SERT, a hypothesis consistent with the elimination of cocaine
conditioned place preference in DAT/SERT double KO mice (Sora et al., 2001).
Furthermore, although fluoxetine, a selective serotonin reuptake inhibitor, has no effect in
wildtype mice, it is rewarding (Hall et al, 2002) and increases striatal dopamine levels in
DAT KO mice (Shen et al., 2004). The locus of this effect may be the VTA/SN, as local
infusions of cocaine in either the dorsal or ventral striatum do not increase extracellular
dopamine levels in DAT KO mice (Mateo et al., 2004; Shen et al., 2004), but local
injections of cocaine or fluoxetine into the VTA do increase extracellular dopamine levels in
the nucleus accumbens of DAT KO, but not wildtype, mice (Mateo et al., 2004). In the
present study, the greatest differences in ΔCBV between KO and wildtype mice were
observed in the VTA/SN. These results are consistent with the hypothesis presented above
that the mechanism of cocaine-induced increases in striatal dopamine in DAT KO mice
involve at least some cocaine actions in the VTA/SN rather than dopaminergic terminal
fields.
DAT KO responses to cocaine are less negative than those of wildtype animals in all brain
regions except the pons, hypothalamus, and medulla oblongata (and not statistically different
in the thalamus). These are all regions that are not involved in drug reward. They display
only modest densities of dopaminergic innervation. Thanos and colleagues (Thanos et al.,
2008) used PET measured 18F-fluorodeoxyglucose (18FDG) uptake in DAT KO and
wildtype mice to assay metabolic activity. They found an overall decrease in
baseline 18FDG uptake in DAT KO versus wildtype mice, and increased uptake after
cocaine challenge in DAT KO mice only in the thalamus and cerebellum. In that PET
study 18FDG was introduced 30 minutes after cocaine injection with an 80 minute
acquisition time. Thus, the 18FDG uptake reflects cocaine effects well after the CBV
changes observed here have returned to baseline. In other studies with rats and primates
using intravenous rather than IP injection of drugs (Jenkins et al., 2004; Marota et al., 2000),
both time to maximum change in CBV and return to baseline are significantly reduced from
values observed here due to different routes of administration. Regardless of how cocaine is
administered, ΔCBV changes measure a fast response of the reward circuit to cocaine
challenge, while 18FDG uptake evaluates longer term responses, averaged over 80 minutes,
that may reflect adaptations to the initial cocaine effect. Taken together, the PET and phMRI
results imply that cocaine impacts the cortico-mesolimbic reward circuit in the first minutes
after challenge with the most impact in the more dopaminergically-innervated anterior
structures. Cocaine subsequently exerts a more sustained influence on the more “limbic”
parts of the circuit.
Conclusion
This study demonstrates the applicability of the CBV weighted phMRI technique to
mapping hemodynamic effects of centrally acting drugs in mouse models of disease. The
technique is minimally invasive and provides good functional sensitivity. We also note that,
as with other functional MRI techniques, the mechanisms underlying the CBV changes may
not be exclusively specific to neuronal activation. The negative ΔCBV response to cocaine
challenge is rapid (~15 min) throughout the reward circuit and attenuated in DAT KO mice.
Since knockout of DAT has a small but significant effect on the immediate response to
cocaine in brain regions thought to be involved in cocaine reward, knockout of DAT appears
to produce circuit-wide changes, not just changes in dopaminergic neurons. The largest
responses to cocaine (−20% to −30% ΔCBV) are seen in the cortex and nucleus accumbens.
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There are decreasing responses in more posterior parts of the reward circuit (CP > AMY >
VTA ~ SN). Nevertheless, some of the greatest differences between DAT KO and wildtype
mice were observed in midbrain structures, VTA and SN, which may indicate a different
mechanism of action of cocaine in DAT KO mice. The fact that there are much more modest
differences in the nucleus accumbens and dorsal striatum between DAT KO and wildtype
mice is consistent with the retention of some cocaine reward, under at least some conditions
(Rocha et al., 1998; Sora et al., 2001; Sora et al., 1998; Thomsen et al., 2009). Thus these
results emphasize the ultimate importance of the nucleus accumbens at early as well as later
stages of drug exposure (Koob and Volkow, 2010).
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Figure 1.
Experimental protocol: In phMRI experiments gradient echo images were acquired
continuously with a time resolution of 1 minute. The baseline intervals before and after P904
injection were 30 minutes each. SpreCA. is the constant baseline signal before contrast agent
injection; SpostCA is the average of five consecutive signals acquired immediately after
contrast agent injection; and S(t) is the time dependent CBV-weighted signal after contrast
agent injection. The acquisitions in the interval between contrast agent and cocaine injection
and the acquisitions at > 60 minutes after cocaine were used to detrend the signal and to
derive the contrast agent washout rate.
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Figure 2.
Effect of IP cocaine on the signal time course in cerebral (nucleus accumbens, open
symbols) and in extra-cerebral tissue (muscle, closed symbols). Injection of 25 mg/kg P904
IV at t = −30 min (left arrow) yields a 62.5% signal drop in nucleus accumbens (4.06 mm3)
and 69.1% signal drop in muscle (9.58 mm3) at TE = 9.5 ms. The second arrow indicates the
IP injection of cocaine (30 mg/kg), which leads to a signal increase in the cerebral tissue
corresponding to a CBV decrease. The error bars show the standard deviation of the signal
within the ROI in a single mouse. This is a typical signal time course prior to detrending.
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Figure 3.
ΔCBV response in two cerebral structures (nucleus accumbens and ventral tegmental area)
to an IP injection of 30 mg/kg cocaine at t = 0. The error bars represent SEM; N = 6 DAT
KO and N = 6 wildtype mice. The continuous black lines are the best gamma variate fit with
the 95% confidence interval shown as dashed gray lines.
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Figure 4.
Quantitative analysis of the regional CBV change after cocaine injection. Peak amplitude
and the time to peak of the gamma variate fit to the signal time course are shown for specific
brain regions. The error bars indicate the standard error of the mean (N = 6 per group). In all
ROIs there is a statistically significant difference (P < 0.01) between DAT KO and wildtype
mice in at least one of the three fitting parameters (the shape factor α is not shown). The
overall time course of the ΔCBV response is statistically different for KO and control mice
in all ROIs except the thalamus. Typical ROI outlines are shown on two coronal brain slices:
prefrontal, frontal and frontoparietal cortex (CTX), nucleus accumbens (ACB), caudate
putamen (CP), amygdala (AMY), hippocampal formation (HPF), thalamic nuclei (TH),
hypothalamus (HY), midbrain (MB), ventral tegmental area (VTA), substantia nigra (SN),
pons (P), medulla (MY), cerebellum (CBX).
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